{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:08:39Z","timestamp":1788804519805,"version":"build-2803163510"},"reference-count":35,"publisher":"L and H Scientific Publishing, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JEAM"],"published-print":{"date-parts":[[2027,3,1]]},"abstract":"<jats:p>Osteoporosis treatment options can be classified into two main groups: anabolic agents and antiresorptive agents. The initial anabolic agent to receive approval is Teriparatide, a 1-34 amino-terminal segment of parathyroid hormone(PTH). In contrast, denosumab, a fully monoclonal antibody, demonstrates strong binding affinity to RANKL, impeding RANKL-RANK interactions, and is recognized as a potent antiresorptive agent. The current model addresses monotherapy limitations by combining denosumab and PTH. Additionally, a proposed mathematical framework explores the temporal effects of plasma PTH and external PTH dosages. This dual-mechanism approach integrates biochemical and biomechanical signals, incorporating key bone remodeling pathways such as RANK-RANKL-OPG and Wnt-Scl-LRP5\/6, along with the role of osteocytes in sensing mechanical stimuli. The primary objective of this study is to predict osteogenic responses with precision by employing mathematical modeling techniques, numerical simulations, stability analysis, sensitivity analysis and control theory approach. This involves evaluating the therapeutic effects of PTH and denosumab, as well as considering various elements within bone signaling pathways that serve as integrating factors in osteoblast-osteoclast interactions. The assessment encompasses the impact of PTH on the glands, denosumab's ability to inhibit RANKL on osteoclasts, and the regulatory functions of Runx_2, p_{CREB}, and Bcl_2 in osteoblast apoptosis and bone volume alterations. The present study conducts numerical evaluation for both pre- and post-menopausal scenarios, considering two cases: prior to and subsequent to preosteoblast saturation. Observation of cell dynamics behavior with and without control, using various weight functions is also conducted. By combining pharmacological and biomechanical insights, this research aims to enhance the clinical significance of osteoporosis treatment, offering a deeper understanding of how combination therapy influences bone remodeling and ultimately improving therapeutic strategies for osteoporosis management.<\/jats:p>","DOI":"10.5890\/jeam.2027.03.003","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:41:02Z","timestamp":1788802862000},"page":"27-78","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing Bone Remodeling: A Control-Theoretic Approach to Model the Combination Therapy of Parathyroid Hormone and Denosumab"],"prefix":"10.5890","volume":"15","author":[{"given":"Amrutha","family":"Sreekumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koyel","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7015","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"[1] Marathe, D.D., Marathe, A., and Mager, D.E. (2011), Integrated model for denosumab and ibandronate pharmacodynamics in postmenopausal women, Biopharmaceutics and Drug Disposition, 32(8), 471-481. https:\/\/doi.org\/10.1002\/bdd.770.","DOI":"10.1002\/bdd.770"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"[2] Ashrafi, M., Gubaua, J.E., Pereira, J.T., Gahlichi, F., and Doblar\u00e9, M. (2020), A mechano-chemo-biological model for bone remodeling with a new mechano-chemo-transduction approach, Biomechanics and Modeling in Mechanobiology, 19, 2499-2523. https:\/\/doi.org\/10.1007\/s10237-020-01353-0.","DOI":"10.1007\/s10237-020-01353-0"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"[3] Aslan, D., Andersen, M.D., Gede, L.B., de Franca, T.K., Jorgensen, S.R., Schwarz, P., and Jorgensen, N.R. (2012), Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans, Scandinavian Journal of Clinical and Laboratory Investigation, 72(1), 14-22. https:\/\/doi.org\/10.3109\/00365513.2011.624631.","DOI":"10.3109\/00365513.2011.624631"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"[4] Silva, B.C. and Bilezikian, J.P. (2015), Parathyroid hormone: anabolic and catabolic actions on the skeleton, Current Opinion in Pharmacology, 22, 41-50. https:\/\/doi.org\/10.1016\/j.coph.2015.03.005.","DOI":"10.1016\/j.coph.2015.03.005"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"[5] Canalis, E., Giustina, A., and Bilezikian, J.P. (2007), Mechanisms of anabolic therapies for osteoporosis, New England Journal of Medicine, 357(9), 905-916.","DOI":"10.1056\/NEJMra067395"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"[6] Bonewald, L.F. and Johnson, M.L. (2008), Osteocytes, mechanosensing and Wnt signaling, Bone, 42(4), 606-615.","DOI":"10.1016\/j.bone.2007.12.224"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"[7] Martin, M., Sansalone, V., Cooper, D.M., Forwood, M.R., and Pivonka, P. (2019), Mechanobiological osteocyte feedback drives mechanostat regulation of bone in a multiscale computational model, Biomechanics and Modeling in Mechanobiology, 18, 1475-1496. https:\/\/doi.org\/10.1007\/s10237-019-01158-w.","DOI":"10.1007\/s10237-019-01158-w"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"[8] Lemaire, V. and Cox, D.R. (2019), Dynamics of bone cell interactions and differential responses to PTH and antibody-based therapies, Bulletin of Mathematical Biology, 81(9), 3575-3622. https:\/\/doi.org\/10.1007\/s11538-018-0533-0.","DOI":"10.1007\/s11538-018-0533-0"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"[9] Pivonka, P., Zimak, J., Smith, D.W., Gardiner, B.S., Dunstan, C.R., Sims, N.A., and Mundy, G.R. (2010), Theoretical investigation of the role of the RANK\u2013RANKL\u2013OPG system in bone remodeling, Journal of Theoretical Biology, 262(2), 306-316. https:\/\/doi.org\/10.1016\/j.jtbi.2009.09.021.","DOI":"10.1016\/j.jtbi.2009.09.021"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"[10] Cook, C.V., Lighty, A.M., Smith, B.J., and Versypt, A.N.F. (2024), A review of mathematical modeling of bone remodeling from a systems biology perspective, Mathematical Biosciences, 367, 109112. https:\/\/doi.org\/10.1016\/j.mbs.2023.109112.","DOI":"10.26434\/chemrxiv-2024-5vrcc"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"[11] Ross, D.S., Mehta, K., and Cabal, A. (2017), Mathematical model of bone remodeling captures the antiresorptive and anabolic actions of various therapies, Bulletin of Mathematical Biology, 79, 117-142. https:\/\/doi.org\/10.1007\/s11538-016-0229-2.","DOI":"10.1007\/s11538-016-0229-2"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"[12] Lavaill, M., Trichilo, S., Scheiner, S., Forwood, M.R., Cooper, D.M., and Pivonka, P. (2020), Study of the combined effects of PTH treatment and mechanical loading in postmenopausal osteoporosis using a new mechanistic PK-PD model, Biomechanics and Modeling in Mechanobiology, 19(5), 1765-1780. https:\/\/doi.org\/10.1007\/s10237-020-01307-6.","DOI":"10.1007\/s10237-020-01307-6"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"[13] Mart\u00ednez-Reina, J., Calvo-Gallego, J.L., Martin, M., and Pivonka, P. (2022), Assessment of strategies for safe drug discontinuation and transition of denosumab treatment in pmo\u2014insights from a mechanistic pk\/pd model of bone turnover, Frontiers in Bioengineering and Biotechnology, 10, 886579. https:\/\/doi.org\/10.3389\/fbioe.2022.886579.","DOI":"10.3389\/fbioe.2022.886579"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"[14] Buck, H.V. and Stains, J.P. (2024), Osteocyte-mediated mechanical response controls osteoblast differentiation and function, Frontiers in Physiology, 15, 1364694. https:\/\/doi.org\/10.3389\/fphys.2024.1364694.","DOI":"10.3389\/fphys.2024.1364694"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"[15] Kendler, D.L., Cosman, F., Stad, R.K., and Ferrari, S. (2022), Denosumab in the treatment of osteoporosis: 10 years later: a narrative review, Advances in Therapy, 39(1), 58-74. https:\/\/doi.org\/10.1007\/s12325-021-01936-y.","DOI":"10.1007\/s12325-021-01936-y"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"[16] Mart\u00ednez-Reina, J., Calvo-Gallego, J.L., and Pivonka, P. (2021), Are drug holidays a safe option in treatment of osteoporosis?\u2014insights from an in silico mechanistic PK\u2013PD model of denosumab treatment of postmenopausal osteoporosis, Journal of the Mechanical Behavior of Biomedical Materials, 113, 104140. https:\/\/doi.org\/10.1016\/j.jmbbm.2020.104140.","DOI":"10.1016\/j.jmbbm.2020.104140"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"[17] Sun, Y., Li, Y., Li, J., Xie, X., Gu, F., Sui, Z., and Yu, T. (2022), Efficacy of the combination of teriparatide and denosumab in the treatment of postmenopausal osteoporosis: a meta-analysis, Frontiers in Pharmacology, 13, 888208. https:\/\/doi.org\/10.3389\/fphar.2022.888208.","DOI":"10.3389\/fphar.2022.888208"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"[18] Kroll, M.H. (2000), Parathyroid hormone temporal effects on bone formation and resorption, Bulletin of Mathematical Biology, 62(1), 163-188. https:\/\/doi.org\/10.1006\/bulm.1999.0146.","DOI":"10.1006\/bulm.1999.0146"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"[19] Rattanakul, C., Lenbury, Y., Krishnamara, N., and Wollkind, D.J. (2003), Modeling of bone formation and resorption mediated by parathyroid hormone: response to estrogen\/PTH therapy, Biosystems, 70(1), 55-72. https:\/\/doi.org\/10.1016\/s0303-2647(03)00040-6.","DOI":"10.1016\/S0303-2647(03)00040-6"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"[20] Komarova, S.V., Smith, R.J., Dixon, S.J., Sims, S.M., and Wahl, L.M. (2003), Mathematical model predicts a critical role for osteoclast autocrine regulation in the control of bone remodeling, Bone, 33(2), 206-215. https:\/\/doi.org\/10.1016\/s8756-3282(03)00157-1.","DOI":"10.1016\/S8756-3282(03)00157-1"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"[21] Lemaire, V., Tobin, F.L., Greller, L.D., Cho, C.R., and Suva, L.J. (2004), Modeling the interactions between osteoblast and osteoclast activities in bone remodeling, Journal of Theoretical Biology, 229(3), 293-309. https:\/\/doi.org\/10.1016\/j.jtbi.2004.03.023.","DOI":"10.1016\/j.jtbi.2004.03.023"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"[22] Pivonka, P., Zimak, J., Smith, D.W., Gardiner, B.S., Dunstan, C.R., Sims, N.A., and Mundy, G.R. (2008), Model structure and control of bone remodeling: a theoretical study, Bone, 43(2), 249-263. https:\/\/doi.org\/doi:10.1016\/j.bone.2008.03.025.","DOI":"10.1016\/j.bone.2008.03.025"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"[23] Peterson, M.C. and Riggs, M.M. (2010), A physiologically based mathematical model of integrated calcium homeostasis and bone remodeling, Bone, 46(1), 49-63. https:\/\/doi.org\/10.1016\/j.bone.2009.08.053.","DOI":"10.1016\/j.bone.2009.08.053"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"[24] Bellido, T., Ali, A.A., Plotkin, L.I., Fu, Q., Gubrij, I., Roberson, P.K., and Jilka, R.L. (2003), Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts: a putative explanation for why intermittent administration is needed for bone anabolism, Journal of Biological Chemistry, 278(50), 50259-50272. https:\/\/doi.org\/10.1074\/jbc.M307444200.","DOI":"10.1074\/jbc.M307444200"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"[25] Jilka, R.L. (2007), Molecular and cellular mechanisms of the anabolic effect of intermittent PTH, Bone, 40(6), 1434-1446. https:\/\/doi.org\/10.1016\/j.bone.2007.03.017.","DOI":"10.1016\/j.bone.2007.03.017"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"[26] Poole, K.E., Van Bezooijen, R.L., Loveridge, N., Hamersma, H., Papapoulos, S.E., L\u00f6wik, C.W., and Reeve, J. (2005), Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation, The FASEB Journal, 19(13), 1842-1844. https:\/\/doi.org\/10.1096\/fj.05-4221fje.","DOI":"10.1096\/fj.05-4221fje"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"[27] Trichilo, S., Scheiner, S., Forwood, M., Cooper, D.M., and Pivonka, P. (2019), Computational model of the dual action of PTH\u2014Application to a rat model of osteoporosis, Journal of Theoretical Biology, 473, 67-79. https:\/\/doi.org\/10.1016\/j.jtbi.2019.04.020.","DOI":"10.1016\/j.jtbi.2019.04.020"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"[28] Mart\u00ednez-Reina, J. and Pivonka, P. (2019), Effects of long-term treatment of denosumab on bone mineral density: insights from an in-silico model of bone mineralization, Bone, 125, 87-95. https:\/\/doi.org\/10.1016\/j.bone.2019.04.022.","DOI":"10.1016\/j.bone.2019.04.022"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"[29] Sreekumar, A. and Chakravarty, K. (2024), Exploring the impact of PTH therapy on bone remodeling: a mathematical investigation, Journal of Biological Systems, 32(02), 809-843. https:\/\/doi.org\/10.1142\/S021833902450027X.","DOI":"10.1142\/S021833902450027X"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"[30] Calvo-Gallego, J.L., Manchado-Morales, P., Pivonka, P., and Mart\u00ednez-Reina, J. (2023), Spatio-temporal simulations of bone remodeling using a bone cell population model based on cell availability, Frontiers in Bioengineering and Biotechnology, 11, 1060158. https:\/\/doi.org\/10.3389\/fbioe.2023.1060158.","DOI":"10.3389\/fbioe.2023.1060158"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"[31] Kahla, R.B. and Barkaoui, A. (2021), Bone Remodeling Process: Mechanics, Biology, and Numerical Modeling, Academic Press.","DOI":"10.1016\/B978-0-323-88467-9.00002-3"},{"key":"ref32","unstructured":"[32] Cook, M.V. (2012), Flight Dynamics Principles: A Linear Systems Approach to Aircraft Stability and Control, Butterworth-Heinemann."},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"[33] Chitnis, N., Hyman, J.M., and Cushing, J.M. (2008), Determining important parameters in the spread of malaria through the sensitivity analysis of a mathematical model, Bulletin of Mathematical Biology, 70, 1272-1296. https:\/\/doi.org\/10.1007\/s11538-008-9299-0.","DOI":"10.1007\/s11538-008-9299-0"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"[34] Samsuzzoha, M.D., Singh, M., and Lucy, D. (2013), Uncertainty and sensitivity analysis of the basic reproduction number of a vaccinated epidemic model of influenza, Applied Mathematical Modelling, 37(3), 903-915. https:\/\/doi.org\/10.1016\/j.apm.2012.03.029.","DOI":"10.1016\/j.apm.2012.03.029"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"[35] Lenhart, S. and Workman, J.T. (2007), Optimal Control Applied to Biological Models, Chapman and Hall\/CRC.","DOI":"10.1201\/9781420011418"}],"container-title":["Journal of Environmental Accounting and Management"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:43:28Z","timestamp":1788803008000},"score":1,"resource":{"primary":{"URL":"https:\/\/lhscientificpublishing.com\/index.php\/jeam\/article\/view\/2500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,3,1]]}},"URL":"https:\/\/doi.org\/10.5890\/jeam.2027.03.003","relation":{},"ISSN":["2325-6192","2325-6206"],"issn-type":[{"value":"2325-6192","type":"print"},{"value":"2325-6206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]}}}